Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Maintains Buy on Axonics, Lowers Price Target to $71

Needham analyst Mike Matson maintains Axonics (NASDAQ:AXNX) with a Buy and lowers the price target from $78 to $71.

November 5, 2021

1 minute read

Needham analyst Mike Matson maintains Axonics (NASDAQ:AXNX) with a Buy and lowers the price target from $78 to $71.

OPEC Jan. Oil Output Rises 210K Barrels/Day Month On Month To 28.01M Barrels/Day; Says Jan. Oil Output Rise Led By Saudi Arabia; Output Falls In Libya, Iraq

Today, 4:52 AM

-Reuters

Today, 4:52 AM

Mizuho analyst Vijay Rakesh maintains Autoliv (NYSE:ALV) with a Buy and lowers the price target from $112 to $109.

Today, 4:52 AM

https://www.marijuanamoment.net/maryland-lawmakers-take-first-step-toward-putting-marijuana-legalization-on-2022-ballot/

Today, 4:52 AM

Barclays analyst Carter Gould maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Overweight and lowers the price target from $136 to $131.